4 studies found for:    deciphera
Show Display Options
Rank Status Study
1 Recruiting A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumors;   Aggressive Systemic Mastocytosis;   Advanced Cancers
Intervention: Drug: DCC-2618
2 Recruiting A Study of DCC-2701 in Participants With Advanced Solid Tumors
Conditions: Locally Advanced Tumors;   Metastatic Solid Tumors;   Cancers With MET Genomic Alterations;   Cancers With TRK Genomic Alterations
Intervention: Drug: DCC-2701 tablet
3 Completed Study Safety and Preliminary Efficacy of DCC-2036 in Patients With Leukemias (Ph+ CML With T315I Mutation)
Condition: Chronic Myeloid Leukemia
Intervention: Drug: DCC-2036
4 Not yet recruiting Rebastinib Plus Antitubulin Therapy With Paclitaxel or Eribulin in Metastatic Breast Cancer
Conditions: Breast Cancer;   Breast Adenocarcinoma;   Human Epidermal Growth Factor 2 Negative Carcinoma of Breast;   Recurrent Breast Carcinoma;   Stage IV Breast Cancer
Interventions: Drug: Rebastinib;   Drug: Paclitaxel;   Drug: Eribulin Mesylate

Indicates status has not been verified in more than two years